doi:

DOI: 10.3724/SP.J.1123.2018.08017

Chinese Journal of Chromatography (色谱) 2018/36:12 PP.1197-1205

Recombination of human galectin-3 with the carbohydrate recognition domain to achieve glycoprotein/glycopeptide enrichment


Abstract:
Though plant lectins have been widely used for the enrichment of glycoproteins/glycopeptides, mammalian lectins have rarely been explored for this purpose. Using the conserved sequence of the carbohydrate recognition domain (CRD) of the human galectin-3 protein, we engineered the following two novel human galectins:Gal3C (containing one CRD) and Tetra-Gal3C (containing four tandem CRDs). Moreover, we designed a galectin affinity column that could be used for glycoprotein/glycopeptide enrichment, by taking advantage of the ability of these recombinant galectins to become immobilized onto streptavidin agarose beads. SDS-PAGE, western blotting, and mass spectrometry were used to characterize the biological features and glycoprotein/glycopeptide enrichment abilities of both these recombinant galectins. Our results showed that both Gal3C and Tetra-Gal3C predominantly enrich glycoproteins/glycopeptides and that this enrichment process has a high specificity and sensitivity. Because Tetra-Gal3C contains three more CRD structural domains, it exhibited a better ability to achieve enrichment than Gal3C. Moreover, the immobilized Gal3C and Tetra-Gal3C were successfully used for the enrichment of glycoproteins from HepG2 cells, which indicated the selective glycoprotein/glycopeptide enrichment potential of recombinant galectins in complex samples.

Key words:liquid chromatography-mass spectrometry (LC-MS),galectin-3 (Gal-3),carbohydrate recognition domain (CRD),glycoprotein enrichment

ReleaseDate:2019-01-03 10:27:19



[1] Barondes S H, Castronovo V, Cooper D, et al. Cell, 1994, 76(4):597

[2] Dumic J, Dabelic S, Fl gel M. Biochim Biophys Acta, Gen Subj, 2006, 1760(4):616

[3] Brinchmann M F, Patel D M, Iversen M H. Mediat Inflamm, 2018, 9186940:1

[4] Zhuang T, Lee H S, Imperiali B, et al. Protein Sci, 2008, 17(7):1220

[5] Johannes L, Jacob R, Leffler H. J Cell Sci, 2018, 131(9):1

[6] Krzeminski M, Singh T, André S, et al. Biochim Biophys Acta, Gen Subj, 2011, 1810(2):150

[7] Pugliese G, Iacobini C, Ricci C, et al. Clin Chem Lab Med, 2014, 52(10):1413

[8] Fortuna-Costa A, Gomes A M, Kozlowski E O, et al. Front Radiat Oncol, 2014, 4:138

[9] Wang M, Tian F, Ying W, et al. Sci Rep, 2017, 7(1):5189

[10] Chou F C, Chen H Y, Kuo C C, et al. Int J Mol Sci, 2018, 19(2):430

[11] Kuno A, Uchiyama N, Koseki-Kuno S, et al. Nat Methods, 2005, 2(11):85

[12] Lu Z, Wang J L, Jia W, et al. Chinese Journal of Chromatography, 2009, 27(1):19 卢庄, 王京兰, 贾伟, 等. 色谱, 2009, 27(1):19

[13] Li F, Kang J W. Chinese Journal of Chromatography, 2014, 32(6):369 李凤, 康经武. 色谱, 2014, 32(6):369

[14] Chikalovets I V, Kovalchuk S N, Litovchenko A P, et al. Fish Shellfish Immunol, 2016, 50:27

[15] Yagi H, Tateno H, Hayashi K, et al. Biosci Biotechnol Biochem, 2017, 81(9):1687

[16] Ambrose S R, Gordon N S, Goldsmith J C, et al. Proteomes, 2015, 3(3):266

[17] Wu J, Zhu J, Yin H, et al. J Proteome Res, 2014, 13(4):2197

[18] Gaj T, Meyer S C, Ghosh I. Protein Expres Purif, 2007, 56(1):54

[19] Cohen M S, Zhang C, Shokat K M, et al. Science, 2005, 308(5726):1318

[20] Weber P C, Ohlendorf D, Wendoloski J, et al. Science, 1989, 243(4887):85

[21] Arthur C M, Rodrigues L C, Baruffi M D, et al. Galectins. New York:Humana Press, 2015

[22] Qiu Y, Patwa T H, Xu L, et al. J Proteome Res, 2008, 7(4):1693

[23] Oguri S. Glycoconjugate J, 2005, 22(7):453

[24] Jin X L, Wang B X, Chen H L, et al. The Practical Journal of Cancer, 2001, 16(2):178 金晓凌, 王炳生, 陈惠黎, 等. 实用癌症杂志, 2001, 16(2):178

[25] Drechsler C, Delgado G, Wanner C, et al. J Am Soc Nephrol, 2015, 26(9):2213

[26] Rahimian R, Béland L C, Kriz J. Drug Discov Today, 2018, 23(2):375

[27] Li L C, Li J, Gao J. J Pharmacol Exp Ther, 2014, 351(2):336